Evidence map›Paper›PMID 37061694›Full record

ArticleTrials2023

VR-SOAP, a modular virtual reality treatment for improving social activities and participation of young people with psychosis: a study protocol for a single-blind multi-centre randomized controlled trial.

Ivo Alexander Meins, Dauw Catharina Muijsson-Bouwman, Saskia Anne Nijman, Kirstin Greaves-Lord, Wim Veling, Gerdina Hendrika Maria Pijnenborg, Elisabeth Christine Dorothée van der Stouwe

Abstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ivo Alexander MeinsUniversity Center of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, Netherlands. i.a.meins@rug.nl.ORCID http://orcid.org/0000-0001-7279-6456
Dauw Catharina Muijsson-BouwmanUniversity Center of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, Netherlands. d.c.muijsson@umcg.nl.
Saskia Anne NijmanUniversity Center of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Kirstin Greaves-LordJonx Groningen, Groningen, Netherlands.
Wim VelingUniversity Center of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Gerdina Hendrika Maria PijnenborgDepartment of Clinical and Developmental Neuropsychology, University of Groningen, Groningen, Netherlands.
Elisabeth Christine Dorothée van der StouweUniversity Center of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.

Funding

NWO Aut.17.003.6617
6 · The paper itself

Abstract

backgroundYoung people with a psychotic disorder have the same social goals as their healthy peers, but their social networks are smaller, they participate less often in leisure activities and are less successful in work and education. Causes of these problems are multifaceted, but culminate in difficulties with interacting in daily life social situations. Current treatments have only moderate effects on social functioning and often target one specific domain. Virtual reality (VR) has the potential to improve the treatment of social interaction difficulties. We developed a modular VR treatment for social functioning and participation (VR-SOAP). In this study, the effect of this intervention will be investigated in a randomized controlled trial (RCT).

methodsA total of 116 participants (age 18-40) with a DSM-5 diagnosis of schizophrenia spectrum or other psychotic disorder and problems with social functioning will be recruited from mental healthcare institutes in the Netherlands. Participants will be randomized to the experimental condition (VR-SOAP) or active VR control condition (VRelax). VR-SOAP consists of 14 sessions and 5 modules addressing causes of impaired social functioning: four optional modules (1-4) and one fixed module (5). Vrelax consists of 14 sessions that entail psychoeducation, stress management, relaxation techniques, and the exploration of relaxing environments in VR. Primary outcomes are quantity and quality of social contacts, leisure activities and social participation, measured with the experience sampling method (ESM). Secondary outcomes are psychiatric symptoms, social behaviour, social cognition, self-esteem, self-stigma and paranoid thoughts. Treatment effects will be compared at pre-treatment (baseline), post-treatment and at 6-month follow-up. DISCUSSION: If VR-SOAP proves to be effective, it provides therapists with a much-needed tool to improve social functioning of young adults with a psychotic disorder. Additionally, since the treatment consists of multiple modules targeting different transdiagnostic factors, this trial might provide input for new treatments to improve social functioning in a range of symptoms and disorders, e.g. mood, autism spectrum and anxiety disorders.

trial registrationOn the 10th of November 2021, this trial was registered prospectively in the Dutch Trial Register as NL9784 .

Indexed as

Cognitive Behavioral TherapyPsychotic DisordersVirtual RealityAdolescentAdultHumansMulticenter Studies as TopicRandomized Controlled Trials as TopicSocial BehaviorTreatment OutcomeYoung AdultPersonalized TreatmentPsychotic disorderSocial functioningVirtual Reality

Identifiers

PMID37061694
PMCPMC10105944

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.